RK

Ranjeet Kumar

Active Director Director DIN 07485891
DIN 07485891 First appointment May 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Ranjeet Kumar

Data last updated:

Ranjeet Kumar is a Director at Adicure Pharma Private Limited (since 2016). The company operates in Trading. Adicure Pharma Private Limited reported revenue of ₹80.9 Lakh (FY 2023).

DIN 07485891
Primary Designation Director
Industry Trading
First Appointment 10 May 2016
Oldest Company Age 10 yrs
Largest company Adicure Pharma Private Limited · ₹80.9 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adicure Pharma Private Limited U51909UP2016PTC083068
Director10 May 20162016₹80.9 Lakh (FY 2023)Active

Board colleagues of Ranjeet Kumar

NameDINCompanyDesignation
Pawan Kumar Yadav07485874Adicure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adicure Pharma Private Limited
Premium access

Shareholding and investment profile for Ranjeet Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjeet Kumar

Ranjeet Kumar currently holds 1 directorship: Adicure Pharma Private Limited (Director, since 10 May 2016, revenue ₹80.9 Lakh (FY 2023)).

Ranjeet Kumar was first appointed on 10 May 2016 as Director at Adicure Pharma Private Limited.

The current boards of Ranjeet Kumar's companies include Pawan Kumar Yadav (Adicure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available